StockData
Immuron Ltd logo

Immuron Ltd (IMRN) income statement

IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 24, 2026Score 4/30
$0.90+0.05 (+5.86%)

Close on Nov 20, 2026Market cap $7.26MP/E –Yield –

See a number that looks wrong?